Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC).

MLA

Bielecka, Zofia F., et al. “Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (CcRCC).” Current Signal Transduction Therapy, vol. 8, no. 3, Dec. 2014, pp. 218–28. EBSCOhost, https://doi.org/10.2174/1574362409666140206223014.

APA

Bielecka, Z. F., Czarnecka, A. M., Solarek, W., Kornakiewicz, A., & Szczylik, C. (2014). Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC). Current Signal Transduction Therapy, 8(3), 218–228. https://doi.org/10.2174/1574362409666140206223014

Chicago

Bielecka, Zofia F, Anna M Czarnecka, Wojciech Solarek, Anna Kornakiewicz, and Cezary Szczylik. 2014. “Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (CcRCC).” Current Signal Transduction Therapy 8 (3): 218–28. doi:10.2174/1574362409666140206223014.